Cystex
NDC 69693-513, methenamine, sodium salicylate, tablet, from Clarion Brands, LLC.
- Product NDC
- 69693-513
- Status
- Listed
- Labeler
- Clarion Brands, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69693-513 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHENAMINE162 mg/1
- SODIUM SALICYLATE162.5 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69693-513-24 | 69693051324 | 1 BLISTER PACK in 1 CARTON (69693-513-24) / 24 TABLET in 1 BLISTER PACK |
| 69693-513-48 | 69693051348 | 1 BLISTER PACK in 1 CARTON (69693-513-48) / 48 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 69693-513 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69693-513 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69693-513. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.